Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic

Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic

There is considerable interest worldwide in developing safe and effective vaccines against COVID-19. Pharma-covigilance of adverse events following immunisation (AEFIs) is a key to making informed decisions regarding the global COVID-19 vaccination campaign. In the Kyrgyz Republic, there have been d...

Full description

Bibliographic Details
Main Authors:	A. A. Zurdinova, Zh. O. Zhumagulova, A. T. Sharaeva, N. Sultanalieva
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	pharmacovigilance adverse event following immunisation aefi novel coronavirus infection covid-19 sars-cov-2 spontaneous reporting monitoring
Online Access:	https://www.risksafety.ru/jour/article/view/343

Similar Items

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
by: AbdulAzeez Adeyemi Anjorin, et al.
Published: (2022-04-01)

A survey of knowledge and reporting practices of primary healthcare workers on adverse experiences following immunisation in alimosho local government area, Lagos
by: Riyike Alaba Ogunyemi, et al.
Published: (2016-01-01)

Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)
by: Cecilia M. Egoavil, et al.
Published: (2020-03-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
by: WANG Qian, et al.
Published: (2022-04-01)

Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess
by: Peter Yamoah, et al.
Published: (2022-11-01)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021-10-01)

Adverse Events Following Immunization with DTP Vaccine in Infants and Children in Kermanshah City: A Cohort Study
by: M Karami, et al.
Published: (2006-02-01)

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01)

Adverse Events Following Vaccination: A Review of Russian and International Terminology
by: A. S. Korovkin, et al.
Published: (2024-04-01)

Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study
by: Semeeh Akinwale Omoleke, et al.
Published: (2022-06-01)

Response: Safety and adverse events following COVID‐19 vaccination among people with epilepsy: Correspondence
by: Marjorie Jia Yi Ong, et al.
Published: (2023-03-01)

Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases
by: Hossein Azarpanah, et al.
Published: (2021-09-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Building confidence in COVID-19 vaccine rollout: the importance of responsible presentation and follow-on investigation of Adverse Events Following Immunization (AEFI) reports for elderly patients
by: Razmin Bari, et al.
Published: (2024-02-01)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018-08-01)

Sterile Abscess Following Hepatitis B Vaccination in a New Born- A Case Report
by: Jisha Myalil Lucca, et al.
Published: (2019-09-01)

Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021
by: Ly Khanh Thi Le, et al.
Published: (2024-02-01)

Vaccine safety: Assessing the prevalence and severity of adverse events following COVID-19 vaccination amongst healthcare workers in tertiary health facilities in Nigeria
by: Ayotunde Sherif Azees, et al.
Published: (2024-01-01)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021-12-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Does This COVID-19 Pandemic Demand a Scale Up in AEFI Reporting in India?
by: Sadhvika Kanagat, et al.
Published: (2022-09-01)

Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection
by: E. V. Zuev, et al.
Published: (2023-10-01)

Polypharmacy problems in geriatric practice of Kyrgyz Republic
by: A. T. Sharaeva, et al.
Published: (2022-11-01)

Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019-03-01)

Safety of equine tetanus antitoxin for prophylactic use in Ethiopia: a retrospective multi-center study
by: Michele Joseph, et al.
Published: (2023-05-01)

Changes in Local and Systemic Adverse Effects following Primary and Booster Immunisation against COVID-19 in an Observational Cohort of Dutch Healthcare Workers Vaccinated with BNT162b2 (Comirnaty<sup>®</sup>)
by: Christiaan Serbanescu-Kele Apor de Zalán, et al.
Published: (2023-12-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Immunisation
by: B Farham
Published: (2023-04-01)

Motivational Factors and Post Vaccination Symptoms among COVID-19 Vaccinated Beneficiaries at a Tertiary Care Hospital, West Bengal, India: A Cross-sectional Study
by: Nabanita Chakraborty, et al.
Published: (2022-10-01)

A field based evaluation of adverse events following MenAfriVac, vaccine delivered in a controlled temperature chain (CTC) approach in Benin
by: Christoph Steffen, et al.
Published: (2014-08-01)

Non-specific effects of vaccinations in high-income settings: How to address the issue?
by: Alberto Donzelli, et al.
Published: (2018-12-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

A Cross-Sectional Study to Assess mRNA-COVID-19 Vaccine Safety among Indian Children (5–17 Years) Living in Saudi Arabia
by: Marya Ahsan, et al.
Published: (2023-01-01)

Australia's contribution to global immunisation
by: Tilman A. Ruff, et al.
Published: (2012-12-01)

Vaccine-associated Arthus reaction
by: Tanatorn Soravipukuntorn, MD, et al.
Published: (2023-09-01)

Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool
by: Bashayer Alshehail, et al.
Published: (2022-04-01)

Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy
by: Niccolò Lombardi, et al.
Published: (2019-08-01)

Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study
by: Agiriye Monima Harry, et al.
Published: (2022-01-01)